Related Experiment Video
Updated: Feb 17, 2026
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
28.7K
Insights
Cardiovascular disease remains a leading cause of death in the US. Expanding the delivery of thrombolytic agents is crucial for treating myocardial infarctions and saving lives.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Cardiovascular disease is the leading cause of mortality in the United States.
- Myocardial infarctions affect 1.5 million individuals annually, with many fatalities occurring before hospital arrival.
Purpose of the Study:
- To highlight the critical need for improved access to thrombolytic agents for acute myocardial infarction treatment.
Main Methods:
- This article reviews current challenges and proposes strategies for enhanced delivery of thrombolytic therapy.
Main Results:
- Delayed administration of thrombolytic agents contributes to poor patient outcomes.
- Expanded and expedited delivery systems are essential for improving survival rates.
Conclusions:
- There is an urgent necessity to broaden the reach and accessibility of life-saving thrombolytic therapies to combat the high mortality associated with myocardial infarctions.
Abstract:
Preview In the United States, cardiovascular disease still causes more deaths than any other health problem. This year, 1.5 million people will have myocardial infarctions, and many will die before they reach the hospital. In this article, Dr Fowles emphasizes the great need for expanded delivery of lifesaving thrombolytic agents.
Related Concept Videos
01:21Myocarditis I: Introduction
460
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
460
01:30Acute Coronary Syndrome I: Introduction
1.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
01:28Acute Coronary Syndrome IV: Interprofessional Care
313
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
01:17Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
01:14Myocarditis III: Medical Management
225
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
01:27Myocarditis II: Clinical Features and Diagnostic Tests
355
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
355